Covered recipient · General Payments record
BRIAN S GOLDFARB
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,937.64
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $715.24 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $367.74 | 15 |
| Bayer HealthCare Pharmaceuticals Inc. | $121.85 | 1 |
| Novo Nordisk AS | $107.53 | 5 |
| GlaxoSmithKline, LLC. | $33.26 | 2 |
| Inspire Medical Systems, Inc. | $26.21 | 1 |
| Corium, Inc. | $25.44 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.51 | 1 |
| Amgen Inc. | $13.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.10 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811078 | CMS |
| ABBVIE INC. | $30.26 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811080 | CMS |
| ABBVIE INC. | $17.29 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811082 | CMS |
| ABBVIE INC. | $19.46 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811084 | CMS |
| ABBVIE INC. | $31.75 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811086 | CMS |
| ABBVIE INC. | $10.32 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811088 | CMS |
| ABBVIE INC. | $19.52 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811090 | CMS |
| ABBVIE INC. | $16.91 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811092 | CMS |
| ABBVIE INC. | $16.05 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811094 | CMS |
| ABBVIE INC. | $31.75 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811096 | CMS |
| ABBVIE INC. | $28.76 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811098 | CMS |
| ABBVIE INC. | $31.75 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811100 | CMS |
| ABBVIE INC. | $28.29 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811102 | CMS |
| ABBVIE INC. | $31.76 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811104 | CMS |
| ABBVIE INC. | $29.77 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811106 | CMS |
| Amgen Inc. | $13.70 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117262393 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $121.85 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086264979 | CMS |
| Corium, LLC | $25.44 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100192507 | CMS |
| GlaxoSmithKline, LLC. | $15.97 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116205748 | CMS |
| GlaxoSmithKline, LLC. | $17.29 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116308901 | CMS |
| Inspire Medical Systems, Inc. | $26.21 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148056975 | CMS |
| Novartis Pharmaceuticals Corporation | $19.51 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086959599 | CMS |
| Novo Nordisk Inc | $19.27 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096701964 | CMS |
| Novo Nordisk Inc | $17.64 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096576561 | CMS |
| Novo Nordisk Inc | $23.98 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097327681 | CMS |
| Novo Nordisk Inc | $23.63 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096605357 | CMS |
| Novo Nordisk Inc | $23.01 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097195261 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.